HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Recurrence of persistent polyclonal B lymphocytosis (PPBL) after rituximab treatment.

AuthorsC Wehr, L Houet, M Pantic, S Gutenberger, F Emmerich, R Marks, P Fisch, Klaus Warnatz
JournalAnnals of hematology (Ann Hematol) Vol. 94 Issue 6 Pg. 1075-6 (Jun 2015) ISSN: 1432-0584 [Electronic] Germany
PMID25638669 (Publication Type: Case Reports, Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Monoclonal, Murine-Derived
  • Immunologic Factors
  • Rituximab
Topics
  • Adult
  • Antibodies, Monoclonal, Murine-Derived (therapeutic use)
  • Female
  • Humans
  • Immunologic Factors (therapeutic use)
  • Lymphocytosis (diagnosis, drug therapy)
  • Recurrence
  • Rituximab
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: